查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1820449

2025 年至 2033 年乳房 X 光摄影市场规模、份额、趋势及按技术、产品和地区分類的预测

Mammography Market Size, Share, Trends and Forecast by Technology, Product, and Region, 2025-2033
出版日期: | 出版商: IMARC | 英文 146 Pages | 商品交期: 2-3个工作天内

价格

2024 年全球乳房 X 光摄影市场规模为 26.4 亿美元。展望未来， IMARC Group估计到 2033 年市场规模将达到 50.6 亿美元，2025 年至 2033 年的复合年增长率为 7.13%。北美目前占据市场主导地位，2024 年的市占率为 43.9%。乳癌发生率上升、人们对早期发现的认识不断提高以及政府支持定期筛检计画的倡议推动了市场的发展。三维 (3D) 断层合成和人工智慧 (AI) 整合等技术进步提高了诊断准确性并促进了采用。不断增长的医疗支出、不断扩大的老年人口以及完善的报销政策进一步巩固了乳房 X 光摄影的市场份额。此外，向微创诊断程序的转变和常规健康检查参与度的提高对市场成长做出了重要贡献，使乳房 X 光摄影成为癌症治疗的重要工具。

推动乳房 X 光摄影市场发展的一大主要因素是全球乳癌发生率的上升，这刺激了对早期检测和筛检解决方案的强劲需求。仅在 2022 年，全球就诊断出约 230 万例乳癌新病例，导致约 67 万人死亡，凸显了及时诊断的紧迫性。乳癌仍然是女性最常见的癌症之一，这促使医疗保健系统优先考虑早期检测策略，以改善存活结果。越来越多的宣传活动和教育计画正在鼓励更多女性定期接受筛检。此外，各国政府和医疗保健组织正在扩大筛检计画和报销支持，以确保更高的可及性。这些倡议将乳房 X 光摄影定位为重要的诊断工具，推动了乳房 X 光摄影市场的持续成长。

美国凭藉其先进的医疗基础设施、较高的乳癌发生率以及对早期发现的高度重视，在乳房 X 光摄影市场占据主导地位，市场份额达 88.20%。 2023 年，约有 79.8% 的 50-74 岁女性在过去两年内接受了乳房 X 光摄影，这突显了在宣传活动、政府支持的筛检计画以及优惠的报销政策的推动下，乳房 X 光摄影的广泛应用。市场受益于先进技术的快速融合，包括 3D 数位乳房 X 光摄影和人工智慧成像，这些技术提高了诊断的准确性。庞大的女性老化人口和不断增长的医疗支出进一步刺激了需求。正在进行的研究、创新和临床试验不断增强乳房影像能力，确保美国在全球乳房 X 光摄影市场前景中保持领先地位。

乳房X光检查市场趋势：

乳房X光检查技术进步

乳房X光检查的普及在很大程度上得益于技术的快速进步，尤其是3D数位乳房断层合成、全视野数位乳房X光检查和人工智慧成像分析等创新技术。这些尖端解决方案能够提供更清晰、更详细的乳房影像，减少假阳性和不必要的活检，从而显着提高诊断准确性。例如，3D乳房X光检查使放射科医生能够逐层检查乳房组织，从而提高癌症检出率，尤其对于乳房组织緻密的女性而言。人工智慧的整合使放射科医生能够更有效率地解读结果，减轻工作量，同时提高检测信心。这些进步增强了患者和医生对乳房X光检查的信任，从而提高了其普及率。此外，主要产业参与者的持续研发确保了更先进、更便利、更具成本效益的系统不断推出。持续的技术进步不仅解决了诊断难题，也加速了市场成长。

乳癌发生率上升

全球乳癌盛行率的上升是乳房X光检查市场的重要趋势。乳癌仍然是女性最常见的癌症，每年报告的新增病例数百万，因此早期发现是医疗保健的首要任务。早期发现可显着改善预后，在筛检阳性族群中，早期确诊的女性五年存活率超过90%。乳房X光检查仍然是乳癌筛检的黄金标准，使临床医生能够在更容易治疗的阶段发现肿瘤。日益加重的疾病负担促使各国政府、非政府组织和医疗机构在全球加强宣传活动，并实施大规模筛检计画。随着越来越多的女性意识到定期体检的重要性，乳房X光检查的普及率正在稳步上升。此外，医疗机构正在扩大诊断设施，提高其可近性，并强化乳房X光检查在降低全球乳癌死亡率方面的重要作用。

政府措施和筛选项目

政府措施和大规模筛检计画在推动乳房 X 光摄影市场发展方面发挥着至关重要的作用，确保了乳房 X 光摄影的广泛可及性和可负担性。许多国家都推出了国家乳癌筛检指南，强製或建议特定年龄层的女性定期进行乳房 X 光摄影。公共卫生运动强调早期发现的重要性，并鼓励人们参与常规筛检。此外，政府的资金、补贴和报销政策也使原本可能面临经济障碍的人更容易获得乳房 X 光摄影服务。例如，美国和欧洲等已开发国家的医疗改革确保了年度或两年一次的筛检覆盖，这显着刺激了需求。在发展中地区，国际合作和非政府组织推动的计画帮助建立了筛检设施和移动乳房 X 光摄影站，涵盖服务匮乏的地区。这些措施不仅提高了公众意识和可近性，也使常规筛检实践规范化，将乳房 X 光摄影定位为全球预防性医疗保健的基石。

目录

第一章：前言

第二章：范围与方法

  • 研究目标
  • 利害关係人
  • 资料来源
    • 主要来源
    • 二手资料
  • 市场评估
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章：执行摘要

第四章：简介

第五章：全球乳房X光检查市场

  • 市场概况
  • 市场表现
  • COVID-19的影响
  • 市场预测

第六章：市场区隔：依技术

  • 乳房断层摄影
  • 电脑辅助设计
  • 数位的

第七章：市场区隔：依产品

  • 电影萤幕系统
  • 数位系统
  • 类比系统
  • 切片系统
  • 3D系统

第八章：市场区隔：依地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲

第九章：SWOT分析

第 10 章：价值链分析

第 11 章：波特五力分析

第 12 章：价格分析

第 13 章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Analogic Corporation
    • Carestream Health (Onex Corporation)
    • Fujifilm Holdings Corporation
    • General Electric Company
    • Hologic Inc.
    • Konica Minolta Inc.
    • Metaltronica SpA
    • Mindray Medical International Limited
    • Koninklijke Philips NV
    • Planmed Oy (Planmeca Oy)
    • Siemens AG
Product Code: SR112025A3984

The global mammography market size was valued at USD 2.64 Billion in 2024. Looking forward, IMARC Group estimates the market to reach USD 5.06 Billion by 2033, exhibiting a CAGR of 7.13% from 2025-2033. North America currently dominates the market, holding a market share of 43.9% in 2024. The market is driven by the rising prevalence of breast cancer, increasing awareness about early detection, and government initiatives supporting regular screening programs. Technological advancements, such as three-dimensional (3D) tomosynthesis and artificial intelligence (AI) integration, enhance diagnostic accuracy and fuel adoption. Growing healthcare expenditure, an expanding elderly population, and improved reimbursement policies further bolsters the mammography market share. Additionally, the shift toward minimally invasive diagnostic procedures and increased participation in routine health check-ups contribute significantly to market growth, making mammography an essential tool in cancer care.

One major driver in the mammography market is the rising prevalence of breast cancer worldwide, which has fueled strong demand for early detection and screening solutions. In 2022 alone, approximately 2.3 million new breast cancer cases were diagnosed globally, leading to around 670,000 deaths, highlighting the urgency of timely diagnosis. Breast cancer remains one of the most common cancers among women, prompting healthcare systems to prioritize early detection strategies to improve survival outcomes. Growing awareness campaigns and education programs are encouraging more women to undergo regular screenings. Additionally, governments and healthcare organizations are expanding screening initiatives and reimbursement support, ensuring greater accessibility. This emphasis positions mammography as a critical diagnostic tool, driving consistent mammography market growth.

The U.S. holds a dominant position in the mammography market with a share of 88.20%, supported by its advanced healthcare infrastructure, high breast cancer incidence, and strong focus on early detection. In 2023, approximately 79.8% of women aged 50-74 underwent a mammogram within the past two years, highlighting widespread adoption driven by awareness campaigns, government-supported screening programs, and favorable reimbursement policies. The market benefits from rapid integration of advanced technologies, including 3D digital mammography and AI-powered imaging, which enhance diagnostic accuracy. A large aging female population and rising healthcare spending further fuel demand. Ongoing research, innovation, and clinical trials continue to strengthen breast imaging capabilities, ensuring sustained U.S. leadership in the global mammography market outlook.

Mammography Market Trends:

Technological Advancements in Mammography

The adoption of mammography is strongly driven by rapid technological advancements, particularly innovations like 3D digital breast tomosynthesis, full-field digital mammography, and AI-powered imaging analysis. These cutting-edge solutions significantly enhance diagnostic accuracy by providing clearer, more detailed breast images, reducing false positives and unnecessary biopsies. For example, 3D mammography allows radiologists to examine breast tissue layer by layer, improving cancer detection rates, especially in women with dense breast tissue. The integration of artificial intelligence supports radiologists in interpreting results more efficiently, reducing workload while improving detection confidence. Such advancements have boosted patient and physician trust in mammography, leading to higher adoption rates. Moreover, continuous research and development by key industry players ensure that more sophisticated, user-friendly, and cost-effective systems are introduced. This ongoing technological progress not only addresses diagnostic challenges but also accelerates market growth.

Rising Prevalence of Breast Cancer

The increasing global prevalence of breast cancer is a key mammography market trend. Breast cancer remains the most commonly diagnosed cancer among women, with millions of new cases reported annually, making early detection a crucial healthcare priority. Early detection greatly improves outcomes, as five-year survival rates exceed 90% for women diagnosed at earlier stages in screening-positive populations. Mammography continues to serve as the gold standard for breast cancer screening, enabling clinicians to identify tumors at more treatable stages. The growing disease burden has pushed governments, NGOs, and healthcare organizations to intensify awareness campaigns and implement large-scale screening programs worldwide. As more women understand the importance of regular check-ups, adoption of mammography is steadily rising. Additionally, healthcare providers are expanding diagnostic facilities, enhancing accessibility and reinforcing mammography's essential role in reducing global breast cancer mortality rates.

Government Initiatives and Screening Programs

Government initiatives and large-scale screening programs play a vital role in driving the mammography market by ensuring widespread access and affordability. Many countries have introduced national breast cancer screening guidelines, mandating or recommending regular mammograms for women in specific age groups. Public health campaigns emphasize the importance of early detection, encouraging participation in routine screenings. Additionally, government funding, subsidies, and reimbursement policies make mammography more accessible to populations that might otherwise face financial barriers. For instance, healthcare reforms in developed nations like the U.S. and Europe ensure coverage for annual or biennial screenings, significantly boosting demand. In developing regions, international collaborations and NGO-driven programs help establish screening facilities and mobile mammography units to reach underserved areas. These initiatives not only increase awareness and access but also normalize routine screening practices, positioning mammography as a cornerstone of preventive healthcare worldwide.

Mammography Industry Segmentation:

Analysis by Technology:

  • Breast Tomosynthesis
  • CAD
  • Digital

According to the mammography market forecast, the digital mammography accounts for the majority of the market share of 64.8%, driven by its ability to deliver high-resolution images, faster results, and enhanced diagnostic precision compared to analog systems. The technology's compatibility with advanced tools such as 3D breast tomosynthesis and AI-driven image analysis further strengthens its clinical value, making it the preferred choice among healthcare providers. Additionally, digital systems streamline workflow efficiency through easy image storage, retrieval, and sharing, reducing delays in diagnosis and treatment. Lower radiation doses, improved patient comfort, and higher detection rates in dense breast tissues contribute to widespread adoption. Supportive government initiatives, reimbursement policies, and the growing demand for advanced screening solutions ensure that digital mammography continues to dominate global market share.

Analysis by Product:

  • Film Screen Systems
  • Digital Systems
  • Analog Systems
  • Biopsy Systems
  • 3D Systems

Digital systems dominate the mammography market demand with a market share of 59.8%, driven by their superior image quality, faster processing, and improved diagnostic accuracy compared to traditional film-based systems. They enable efficient storage, retrieval, and sharing of images through picture archiving and communication systems (PACS), supporting streamlined workflows and remote consultations. Digital mammography also facilitates advanced technologies like 3D tomosynthesis and AI integration, enhancing early cancer detection and reducing false positives. Hospitals and diagnostic centers prefer these systems due to lower long-term operational costs, reduced radiation exposure, and higher patient throughput. Growing awareness, government support, and reimbursement for digital screenings further accelerate adoption, solidifying digital mammography's position as the standard choice in modern breast imaging practices.

Regional Analysis:

  • North America
    • United States
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

Based on the mammography market analysis, North America is the leading region with a market share of 43.9% driven by its advanced healthcare infrastructure, high adoption of cutting-edge imaging technologies, and strong emphasis on early breast cancer detection. The region benefits from widespread awareness campaigns, supportive government policies, and comprehensive reimbursement systems that encourage routine screenings. A significant prevalence of breast cancer, coupled with a growing aging population, fuels continuous demand for mammography services. Additionally, rapid integration of innovations such as 3D tomosynthesis and AI-based imaging strengthens diagnostic capabilities and patient confidence. Strong investments in research, clinical trials, and healthcare digitization further contribute to the region's dominance, positioning North America as a global hub for mammography advancements and early detection initiatives.

Key Regional Takeaways:

United States Mammography Market Analysis

The United States mammography market is primarily driven by the increasing awareness about the importance of early breast cancer detection. In line with this, continual technological advancements such as digital mammography and 3D imaging, enhancing diagnostic accuracy and precision, are impelling the market. The growing aging population is also contributing to a higher incidence of breast cancer, further fueling market demand. According to the U.S. Census Bureau's Vintage 2024 Population Estimates, the U.S. population aged 65 and older increased by 3.1%, reaching 61.2 million, while the population under age 18 decreased by 0.2%, totaling 73.1 million, from 2023 to 2024. Additionally, supportive government initiatives and the expansion of insurance coverage for preventive care are stimulating market appeal. The rising healthcare expenditure in the U.S., which enables greater investments in advanced imaging systems, is propelling market growth. Furthermore, the heightened prevalence of dense breast tissue, which drives the need for specialized imaging solutions, is fostering market expansion. The rapid integration of artificial intelligence in mammography is improving both diagnostic speed and accuracy. Moreover, the increasing focus on women's health and wellness is creating lucrative opportunities in the market.

Europe Mammography Market Analysis

The European market is experiencing growth attributed to the increasing prevalence of breast cancer. Europe, representing 9% of the global population, accounts for 20.3% of cancer deaths and 23.4% of diagnoses. As per the European Cancer Information System, in 2022, 2.74 million new cancer cases were reported, with projections indicating over 3.24 million cases by 2040, highlighting the need for early detection. In accordance with this, the increasing adoption of advanced digital and 3D mammography technologies is improving diagnostic accuracy and market accessibility. The rising focus on preventive healthcare programs is further enhancing screening rates. Similarly, the expansion of public and private insurance coverage is making mammography more affordable, contributing to market growth. The ongoing integration of artificial intelligence in mammography systems, which optimizes diagnostic processes and reduces human error, is strengthening market demand. Furthermore, increasing awareness of women's health and wellness, driving more initiatives aimed at breast cancer prevention, is enhancing market appeal. The aging population in Europe, which faces a higher risk of breast cancer, is also contributing to the market development. Besides this, strategic investments in healthcare infrastructure are accelerating the adoption of these advanced screening technologies.

Asia Pacific Mammography Market Analysis

The mammography market in the Asia Pacific is largely propelled by the rising prevalence of breast cancer, which is increasing the demand for early detection solutions. According to NCBI, breast cancer is a major health issue in Asia, with an estimated 985.4 thousand new cases and 315.1 thousand deaths reported in 2022. The age-standardized incidence and mortality rates are 34.3 and 10.5 per 100,000, respectively, highlighting the critical need for effective screening and early detection. Additionally, continuous improvements in healthcare infrastructure are enhancing access to advanced diagnostic technologies like digital mammography. The strong government initiatives and public health campaigns are further encouraging regular breast screenings. Furthermore, the growing awareness among women about breast cancer prevention is contributing to the increased adoption of mammography services. The increasing availability and affordability of advanced imaging technologies are augmenting market growth. Moreover, the expansion of private healthcare facilities offering specialized diagnostic services is improving access to high-quality mammography, thereby impacting the market trends.

Latin America Mammography Market Analysis

In Latin America, the market is expanding due to increasing healthcare investments aimed at improving cancer detection services. As such, in January 2025, Mamotest secured a USD 1.5 Million investment from Philips Foundation to scale AI-driven breast cancer care. The funding will enhance diagnostics, improve patient outcomes, and expand Mamotest's reach in Latin America and Europe, benefiting underserved populations. Similarly, the rising awareness campaigns focused on breast cancer prevention are encouraging women to undergo regular screenings. The expansion of healthcare insurance coverage is increasing access to mammography, particularly in underserved areas. Moreover, the growing adoption of advanced imaging technologies, such as digital and 3D mammography, is improving diagnostic accuracy and fueling demand for more effective screening solutions, providing an impetus to the market.

Middle East and Africa Mammography Market Analysis

The mammography market in the Middle East and Africa is influenced by the rising healthcare investments in both public and private sectors, enhancing access to advanced diagnostic tools. Similarly, favorable government initiatives promoting women's health and preventive care are further supporting market demand. The heightened awareness of breast cancer prevention, leading to higher screening rates, is fostering market expansion. In Saudi Arabia, breast cancer is the most common cancer among women. A study in Arar City showed 84.2% awareness of breast self-examination (BSE), with 80% of participants having good knowledge of BSE and mammography. Furthermore, the growing adoption of mobile health solutions and telemedicine is expanding access to mammography services, especially in remote areas.

Competitive Landscape:

The competitive landscape is characterized by intense innovation, technological advancement, and strategic expansion. Market players focus heavily on developing advanced imaging solutions, such as 3D tomosynthesis, digital breast imaging, and AI-powered diagnostic tools, to improve accuracy and efficiency. Competition is fueled by the rising demand for early detection technologies, pushing companies to enhance product portfolios and invest in research and development (R&D). Additionally, partnerships with healthcare providers, regulatory approvals, and global distribution networks are crucial strategies for gaining market share. The landscape also reflects a balance between established manufacturers offering premium solutions and emerging players providing cost-effective alternatives, creating a dynamic environment that drives continuous technological progress and accessibility worldwide.

The report provides a comprehensive analysis of the competitive landscape in the mammography market with detailed profiles of all major companies.

Key Questions Answered in This Report

  • 1.How big is the mammography market?
  • 2.What is the future outlook of mammography market?
  • 3.What are the key factors driving the mammography market?
  • 4.Which region accounts for the largest mammography market share?
  • 5.Which are the leading companies in the global mammography market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Mammography Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Technology

  • 6.1 Breast Tomosynthesis
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 CAD
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Digital
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Product

  • 7.1 Film Screen Systems
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Digital Systems
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Analog Systems
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Biopsy Systems
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 3D Systems
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by Region

  • 8.1 North America
    • 8.1.1 United States
      • 8.1.1.1 Market Trends
      • 8.1.1.2 Market Forecast
    • 8.1.2 Canada
      • 8.1.2.1 Market Trends
      • 8.1.2.2 Market Forecast
  • 8.2 Asia-Pacific
    • 8.2.1 China
      • 8.2.1.1 Market Trends
      • 8.2.1.2 Market Forecast
    • 8.2.2 Japan
      • 8.2.2.1 Market Trends
      • 8.2.2.2 Market Forecast
    • 8.2.3 India
      • 8.2.3.1 Market Trends
      • 8.2.3.2 Market Forecast
    • 8.2.4 South Korea
      • 8.2.4.1 Market Trends
      • 8.2.4.2 Market Forecast
    • 8.2.5 Australia
      • 8.2.5.1 Market Trends
      • 8.2.5.2 Market Forecast
    • 8.2.6 Indonesia
      • 8.2.6.1 Market Trends
      • 8.2.6.2 Market Forecast
    • 8.2.7 Others
      • 8.2.7.1 Market Trends
      • 8.2.7.2 Market Forecast
  • 8.3 Europe
    • 8.3.1 Germany
      • 8.3.1.1 Market Trends
      • 8.3.1.2 Market Forecast
    • 8.3.2 France
      • 8.3.2.1 Market Trends
      • 8.3.2.2 Market Forecast
    • 8.3.3 United Kingdom
      • 8.3.3.1 Market Trends
      • 8.3.3.2 Market Forecast
    • 8.3.4 Italy
      • 8.3.4.1 Market Trends
      • 8.3.4.2 Market Forecast
    • 8.3.5 Spain
      • 8.3.5.1 Market Trends
      • 8.3.5.2 Market Forecast
    • 8.3.6 Russia
      • 8.3.6.1 Market Trends
      • 8.3.6.2 Market Forecast
    • 8.3.7 Others
      • 8.3.7.1 Market Trends
      • 8.3.7.2 Market Forecast
  • 8.4 Latin America
    • 8.4.1 Brazil
      • 8.4.1.1 Market Trends
      • 8.4.1.2 Market Forecast
    • 8.4.2 Mexico
      • 8.4.2.1 Market Trends
      • 8.4.2.2 Market Forecast
    • 8.4.3 Others
      • 8.4.3.1 Market Trends
      • 8.4.3.2 Market Forecast
  • 8.5 Middle East and Africa
    • 8.5.1 Market Trends
    • 8.5.2 Market Breakup by Country
    • 8.5.3 Market Forecast

9 SWOT Analysis

  • 9.1 Overview
  • 9.2 Strengths
  • 9.3 Weaknesses
  • 9.4 Opportunities
  • 9.5 Threats

10 Value Chain Analysis

11 Porters Five Forces Analysis

  • 11.1 Overview
  • 11.2 Bargaining Power of Buyers
  • 11.3 Bargaining Power of Suppliers
  • 11.4 Degree of Competition
  • 11.5 Threat of New Entrants
  • 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 Analogic Corporation
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
      • 13.3.1.3 SWOT Analysis
    • 13.3.2 Carestream Health (Onex Corporation)
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
    • 13.3.3 Fujifilm Holdings Corporation
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
      • 13.3.3.3 Financials
      • 13.3.3.4 SWOT Analysis
    • 13.3.4 General Electric Company
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
      • 13.3.4.3 Financials
      • 13.3.4.4 SWOT Analysis
    • 13.3.5 Hologic Inc.
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
      • 13.3.5.3 Financials
      • 13.3.5.4 SWOT Analysis
    • 13.3.6 Konica Minolta Inc.
      • 13.3.6.1 Company Overview
      • 13.3.6.2 Product Portfolio
      • 13.3.6.3 Financials
      • 13.3.6.4 SWOT Analysis
    • 13.3.7 Metaltronica S.p.A.
      • 13.3.7.1 Company Overview
      • 13.3.7.2 Product Portfolio
    • 13.3.8 Mindray Medical International Limited
      • 13.3.8.1 Company Overview
      • 13.3.8.2 Product Portfolio
    • 13.3.9 Koninklijke Philips N.V.
      • 13.3.9.1 Company Overview
      • 13.3.9.2 Product Portfolio
      • 13.3.9.3 Financials
      • 13.3.9.4 SWOT Analysis
    • 13.3.10 Planmed Oy (Planmeca Oy)
      • 13.3.10.1 Company Overview
      • 13.3.10.2 Product Portfolio
    • 13.3.11 Siemens AG
      • 13.3.11.1 Company Overview
      • 13.3.11.2 Product Portfolio
      • 13.3.11.3 Financials
      • 13.3.11.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Mammography Market: Major Drivers and Challenges
  • Figure 2: Global: Mammography Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Mammography Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Mammography Market: Breakup by Technology (in %), 2024
  • Figure 5: Global: Mammography Market: Breakup by Product (in %), 2024
  • Figure 6: Global: Mammography Market: Breakup by Region (in %), 2024
  • Figure 7: Global: Mammography (Breast Tomosynthesis) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 8: Global: Mammography (Breast Tomosynthesis) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 9: Global: Mammography (CAD) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 10: Global: Mammography (CAD) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 11: Global: Mammography (Digital) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 12: Global: Mammography (Digital) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 13: Global: Mammography (Film Screen Systems) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 14: Global: Mammography (Film Screen Systems) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 15: Global: Mammography (Digital Systems) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 16: Global: Mammography (Digital Systems) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 17: Global: Mammography (Analog Systems) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 18: Global: Mammography (Analog Systems) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 19: Global: Mammography (Biopsy Systems) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 20: Global: Mammography (Biopsy Systems) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 21: Global: Mammography (3D Systems) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 22: Global: Mammography (3D Systems) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 23: North America: Mammography Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 24: North America: Mammography Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 25: United States: Mammography Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 26: United States: Mammography Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 27: Canada: Mammography Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 28: Canada: Mammography Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 29: Asia-Pacific: Mammography Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 30: Asia-Pacific: Mammography Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 31: China: Mammography Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 32: China: Mammography Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 33: Japan: Mammography Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 34: Japan: Mammography Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 35: India: Mammography Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 36: India: Mammography Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 37: South Korea: Mammography Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 38: South Korea: Mammography Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 39: Australia: Mammography Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 40: Australia: Mammography Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 41: Indonesia: Mammography Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 42: Indonesia: Mammography Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 43: Others: Mammography Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 44: Others: Mammography Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 45: Europe: Mammography Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 46: Europe: Mammography Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 47: Germany: Mammography Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 48: Germany: Mammography Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 49: France: Mammography Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 50: France: Mammography Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 51: United Kingdom: Mammography Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 52: United Kingdom: Mammography Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 53: Italy: Mammography Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 54: Italy: Mammography Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 55: Spain: Mammography Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 56: Spain: Mammography Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 57: Russia: Mammography Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 58: Russia: Mammography Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 59: Others: Mammography Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 60: Others: Mammography Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 61: Latin America: Mammography Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 62: Latin America: Mammography Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 63: Brazil: Mammography Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 64: Brazil: Mammography Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 65: Mexico: Mammography Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 66: Mexico: Mammography Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 67: Others: Mammography Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 68: Others: Mammography Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 69: Middle East and Africa: Mammography Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 70: Middle East and Africa: Mammography Market: Breakup by Country (in %), 2024
  • Figure 71: Middle East and Africa: Mammography Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Global: Mammography Industry: SWOT Analysis
  • Figure 73: Global: Mammography Industry: Value Chain Analysis
  • Figure 74: Global: Mammography Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Mammography Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Mammography Market Forecast: Breakup by Technology (in Million USD), 2025-2033
  • Table 3: Global: Mammography Market Forecast: Breakup by Product (in Million USD), 2025-2033
  • Table 4: Global: Mammography Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 5: Global: Mammography Market: Competitive Structure
  • Table 6: Global: Mammography Market: Key Players